Clinical Trials
27 trialsA Study of Voice as a Way to Monitor for Side Effects in People Receiving CAR T-Cell Therapy
Memorial Sloan Kettering Cancer Center
Infectious Complications in Hematological Patients Under Treatment With Bispecific Antibodies.
Infanta Leonor University Hospital
Collection of Tissue Samples for Cancer Research
National Institutes of Health Clinical Center (CC)
Biospecimen Procurement for Center for Immuno-Oncology Immunotherapy Protocols
National Institutes of Health Clinical Center (CC)
LEADER
Takeda
Neurocognitive Outcomes After Whole Brain Radiation Therapy for Hematologic Malignancies
M.D. Anderson Cancer Center
Biomarker for Infection Risk in CLL and MM
Massachusetts General Hospital
COSMIC
ASH Research Collaborative
MUST
Pfizer
National Cancer Institute "Cancer Moonshot Biobank"
National Cancer Institute (NCI)
Biospecimen Collection in Identifying Genetic Changes in Patients With Breast, Prostate, Colorectal, Liver, or Kidney Cancer or Multiple Myeloma Undergoing Surgery
National Cancer Institute (NCI)
Towards Effective, Patient-tailored Anti-plasma Cell Therapies in AL Amyloidosis: Predicting Drug Response and Overcoming Drug Resistance
Fondazione IRCCS Policlinico San Matteo di Pavia
Anonymization of Clinical Data From Pseudonymized Databases Collected as Part of Previus Clinical Trials on Multiple Myeloma
IRCCS Azienda Ospedaliero-Universitaria di Bologna
MMAPPIN' Study: Multiple Myeloma Analysis For Patient-specific Insights to Dissect Disease Heterogeneity
IRCCS Azienda Ospedaliero-Universitaria di Bologna
LONGEVITI
University of Alberta
MoMMent
Janssen Pharmaceutica N.V., Belgium
REALiTEC/TAL
Janssen-Cilag Ltd.
iPREFER
The Christie NHS Foundation Trust
A Real-world Study in Participants With Smoldering Multiple Myeloma
Janssen-Cilag Ltd.
Study of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical Outcome
Dana-Farber Cancer Institute
Predicting Progression of Developing Myeloma in a High-Risk Screened Population (PROMISE)
Dana-Farber Cancer Institute
A Real World Study of Elranatamab in Patients With RR Multiple Myeloma in Taiwan
Pfizer
ALPS
Fondazione IRCCS Policlinico San Matteo di Pavia
Questionnaire and Tissue Banking For Multiple Myeloma, Waldenstrom Macroglobulinemia and Related Disorders
Dana-Farber Cancer Institute
Tissue Collection for Studies of Lymph Cancer
National Institutes of Health Clinical Center (CC)
iCaRe2
University of Nebraska
RISE
Gruppo Italiano Malattie EMatologiche dell'Adulto